Venetia Sarode

Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors

Xiumei Huang, Edward A. Motea, Zachary Moore et al. · Cancer Cell · 2016 · 127 citations · Full text

Nqo1 Bioactivatable Drug, Tumor Biology, Polymer-drug Conjugate +12

Decreased Androgen Receptor Expression Is Associated With Distant Metastases in Patients With Androgen Receptor–Expressing Triple-Negative Breast Carcinoma

Lisa Sutton, Dengfeng Cao, Venetia Sarode et al. · American Journal of Clinical Pathology · 2012 · 105 citations · Full text

Androgen Receptor, Endocrine Oncology, Breast Oncology +14

KIF14 Promotes AKT Phosphorylation and Contributes to Chemoresistance in Triple-Negative Breast Cancer

Stina Mui Singel, Crystal Cornelius, Elma Zaganjor et al. · Neoplasia · 2014 · 103 citations · Full text

Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer

D H Morrison, Dewi Rahardja, Ellen King et al. · British Journal of Cancer · 2012 · 100 citations · Full text

Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis

David E. Gerber, Muhammad Shaalan Beg, Farjana Fattah et al. · British Journal of Cancer · 2018 · 91 citations · Full text